Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: methotrexate

2013 ACR/ARHP Annual Meeting: Rheumatology Year in Review

Mary Beth Nierengarten  |  December 1, 2013

Progress in treatments for pediatric rheumatic diseases, collaborative clinical trials, and personalized therapeutic approaches highlight the past year in rheumatology

Filed under:ConditionsDrug UpdatesMeeting ReportsPediatric ConditionsRheumatoid Arthritis Tagged with:clinical trialsDiseasePediatricreviewrheumatologytargeted therapyTreatment

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  November 1, 2013

Information on new approvals and medication safety that rheumatologists need to know

Filed under:Drug Updates Tagged with:DrugsFDArheumatologySafety

What Diet to Recommend to Patients with Rheumatoid Arthritis?

Vanessa Caceres  |  November 1, 2013

With no clear-cut, evidence-based dietary guidelines for RA, rheumatologists should advocate for a balanced diet to help patients reduce their risk of obesity, cardiovascular disease, and osteoporosis

Filed under:ConditionsRheumatoid Arthritis Tagged with:Dietevidence-based guidelinesnutritionRheumatoid arthritis

Fellow’s Forum Case Report: New Sarcoidosis Cases in Patients Treated with Tumor Necrosis Factor–Alpha Inhibitors

Jonida Cote, DO, Thomas Harrington, MD, Alicia Meadows, DO, Fan Lin, MD, and Androniki Bili, MD, MPH  |  November 1, 2013

Two patients with psoriatic arthritis treated with TNF-alpha inhibitor therapy develop the multisystem disease

Filed under:ConditionsOther Rheumatic ConditionsPsoriatic Arthritis Tagged with:Psoriatic ArthritisSarcoidosisTherapiesTreatmentTumor Necrosis Factor–Alpha Inhibitor

Under the Radar

Sarah Schafer, MD  |  November 1, 2013

A physician–patient’s experience with Sjögren’s syndrome

Filed under:ConditionsProfilesSjögren’s Disease Tagged with:DiagnosisphysicianSjogren'ssymptoms

Choosing Wisely’s Treatments, Tests that Pediatric Rheumatologists and Patients Should Question

Kurt Ullman  |  November 1, 2013

From autoantibody panels to assays for Lyme disease, the ACR and ABIM Foundation identify five common tests that are expensive, potentially harmful, and may not improve patient care

Filed under:ConditionsPediatric ConditionsPractice Support Tagged with:AC&RPediatrictests

EULAR 2013: New RA Recommendations Address Combination Therapy Concerns

Thomas R. Collins  |  October 1, 2013

Guidelines give greater nod to use of combination conventional disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis, leave monotherapy with methotrexate as acceptable first-line treatment

Filed under:Drug UpdatesMeeting Reports Tagged with:Disease-modifying antirheumatic drugs (DMARDs)EULARMethotrexateRheumatoid arthritistherapy

ACR Issues sJIA Recommendations, SSc Classification Criteria

Kathy Holliman  |  October 1, 2013

Guidelines address advances in pathophysiology and treatment of systemic juvenile idiopathic arthritis; criteria classify broader spectrum of systemic sclerosis

Filed under:ConditionsOther Rheumatic ConditionsSystemic Sclerosis Tagged with:AC&RrecommendationsJIASScsystemic juvenile idiopathic arthritisSystemic sclerosis

New Insights into CPPD

Robert Terkeltaub, MD  |  October 1, 2013

Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:DiseaseResearchTreatment

Speak Out Rheum: Under the Radar

Sarah Schafer, MD  |  September 10, 2013

A physician–patient’s experience with Sjögren’s syndrome

Filed under:ConditionsSjögren’s Disease Tagged with:Dry eyeSjogren's

  • « Previous Page
  • 1
  • …
  • 83
  • 84
  • 85
  • 86
  • 87
  • …
  • 105
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences